10.1016/j.cell.2009.03.045 64 KreJ
In vitro experiments confirmed that A 25-35 treatment significantly inhibited the activation of the NRF2/SLC7A11/GPX4 signaling pathway in HT22 cells, upregulated the expression of Fe 2+ , TFR1, ACSL4, MDA, and GSSG, and decreased the expression of FTH1, SOD, and GSH, as well as the GSH/GSSG ratio, resulting in dysregulated neuronal iron metabolism, impaired amino acid antioxidant systems, mitochondrial dysfunction, and ferroptosis, which ultimately promoted neuronal injury
Characteristics of PFIC and PFIC-related diseases in paediatric populations PFIC causes progressive intrahepatic cholestasis in newborns, infants, and children
Similar GH-releasing potency
This decline is linked to a decreased capacity for tissue regeneration, which is why GHK-Cu has become a cornerstone of so much longevity and dermatological research